News
AstraZeneca's shares are up 3.5% over the year to date but remain down 11% over the past 52 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback